|
Detection of actionable gene mutations in breast cancer by amplicon-based next-generation sequencing liquid biopsy. |
|
|
Employment - Lucence Diagnostics |
|
|
No Relationships to Disclose |
|
|
Employment - Lucence Diagnostics |
|
|
Employment - Lucence Diagnostics |
|
|
Employment - Lucence Diagnostics |
|
|
Employment - Lucence Diagnostics |
|
|
Employment - Lucence Diagnostics |
|
|
No Relationships to Disclose |
|
|
Employment - Lucence Diagnostics |
Leadership - Lucence Diagnostics |
Stock and Other Ownership Interests - Lucence Diagnostics |
Patents, Royalties, Other Intellectual Property - Drug delivery technology, diagnostics technology |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |